Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

7 Tools to Identify Depression

Nancy Sharby, PT, DPT, MS  |  Issue: August 2014  |  August 1, 2014

The test does not come with a standard cut-off point for a positive screen, which is to be determined by the examiner based on information about the context of the clinical setting. Administration of the BDI-PC to 120 patients making non-mental health-related visits to physicians found that a cut-off score of 4 out of a possible 21 points was clinically significant.23 In this study population, the sensitivity was .97 with a specificity of .99.23

Another frequently used screening tool is the Hospital Anxiety and Depression Scale (HADS), which was designed to be used with patients who are receiving medical care. Thus, the tool has the advantage that it does not contain any questions that refer to somatic symptoms. This test is the most widely tested of all the screening tools among patients with co-occurring medical conditions and has strong validity when compared with other validated tools. Further, the findings remain valid when compared to the structured mental health interview.24

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The HADS contains 14 items, seven for depression and seven for anxiety. Taken together, they reflect mental disorders. Each item is scored on a four-point scale from 0 (not present) to 3 (present to a considerable degree). One review found that a cut-off score of 5 for depression produced optimal specificity and sensitivity.21 However, another investigation in patients seen in general medical practice found the best information came with a cut-off score of 8 or higher.11

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Table 3: 2 Questions from the PRIME-MD

click for large version
Table 3: 2 Questions from the PRIME-MD

The CES-D was developed for use in a general medical setting. It is a 20-item scale that asks the patient how frequently they have experienced certain symptoms over the past week. Each item is scored from 0 (no days or rarely) to 3 (five to seven days). Thus, it yields a score from 0–60. A cut-off score of 16 or greater is highly indicative for depression. Some of the 20 questions, such as lack of appetite, having restless sleep and feeling everything required great effort, ask for symptoms that overlap with symptoms of arthritis. Studies indicated that the CES-D had only moderate agreement with a structured interview.

In a study of elderly patients, the sensitivity was 100% and the specificity 88%, compared with a sample of patients in a primary clinic in which the specificity was 79.5% and the specificity was 71%.25 In patients with RA, a cut-off score of 19 was most appropriate due to overlapping symptoms of RA and depression.26

Page: 1 2 3 4 5 6 7 8 9 10 | Single Page
Share: 

Filed under:Career DevelopmentConditionsEducation & TrainingOsteoarthritis and Bone DisordersProfessional TopicsResearch RheumRheumatoid ArthritisVasculitis Tagged with:Association of Rheumatology Professionals (ARP)DepressionOsteoarthritispatient carepsychological disorderResearchRheumatoid arthritisscreeningsymptom

Related Articles

    Depression in Rheumatoid Arthritis

    November 1, 2012

    Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression

    Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

    December 1, 2014

    A review of data on antinuclear antibodies and tests for rheumatoid arthritis

    Study Examines How Depression Subtypes May Stem from Osteoarthritis

    October 18, 2019

    People with or at risk for sympto­matic knee osteoarthritis (OA) may be assigned to four depression subtypes with distinct clusters of depressive symptoms that may affect pain and disability over time, according to a new study in Arthritis Care & Research.1 Four depression subtypes were identified in the study using the Center for Epidemiologic Studies…

    Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting

    April 2, 2014

    Observational pain scales, diagnostic tools, pharmacologic interventions, and support from psychologists, caregivers recommended

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences